2B30

ICD-11 MMS 2026-01

Hodgkin lymphoma

Description

Hodgkin lymphomas, previously known as Hodgkin's disease, characterised by the presence of large tumour cells in an abundant admixture of nonneoplastic cells. There are two distinct subtypes: nodular lymphocyte predominant Hodgkin lymphoma and classical Hodgkin lymphoma. Hodgkin lymphoma involves primarily lymph nodes.

Exclusions from above levels

  • 2E03 – Malignant neoplasm metastasis in bone or bone marrow
  • http://id.who.int/icd/entity/501778925 – Malignant neoplasm metastasis in lymph nodes
  • http://id.who.int/icd/entity/97145147 – Malignant neoplasm metastasis in thymus gland

Child codes

  • 2B30.0 – Nodular lymphocyte predominant Hodgkin lymphoma
  • 2B30.1 – Classical Hodgkin lymphoma
  • 2B30.Z – Hodgkin lymphoma, unspecified

Sibling codes

  • 2A60 – Acute myeloid leukaemias and related precursor neoplasms
  • 2A61 – Acute leukaemias of ambiguous lineage
  • 2B31 – Histiocytic or dendritic cell neoplasms
  • 2B32 – Immunodeficiency-associated lymphoproliferative disorders
  • 2B33 – Malignant haematopoietic neoplasms without further specification
  • 2B3Z – Neoplasms of haematopoietic or lymphoid tissues, unspecified

Foundation entity

Hodgkin lymphoma – http://id.who.int/icd/entity/1528863768

Allowed postcoordination axes

Part of: 02: Neoplasms